{"name":"Oxymorphone","slug":"oxymorphone","kind":"substance","abbreviations":[],"systematic":null,"aliases":["Oximorphonum","14-Hydroxydihydromorphinone","Dihydrohydroxymorphinone","Dihydroxymorphinone","Oximorfona","(-)-Oxymorphone","7,8-Dihydro-14-hydroxymorphinone","Oxymorphonum","Oxymorphone cii","Dihydro-14-hydroxymorphinone"],"brands":[],"scraped":true,"has_structure":true,"cid":5284604,"classes":[{"name":"opioid","href":"/class/opioid"}],"families":[{"name":"2-benzylpiperidine","href":"/substituted/2-benzylpiperidine"}],"physical":[{"label":"Molecular mass","value":"301.34 g/mol","copyable":false},{"label":"Appearance","value":"Crystals from boiling ethanol, ethyl acetate, or benzene","copyable":false},{"label":"Melting point","value":"248-249 °C","copyable":false},{"label":"Solubility","value":"24000 mg/L","copyable":false},{"label":"Predicted LogP","value":"0.8","copyable":false}],"identifiers":[{"label":"Molecular formula","value":"C<sub>17</sub>H<sub>19</sub>NO<sub>4</sub>","copyable":true},{"label":"IUPAC name","value":"(4R,4aS,7aR,12bS)-4a,9-dihydroxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one","copyable":true},{"label":"SMILES","value":"CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)O)O4)O","copyable":true},{"label":"InChI","value":"InChI=1S/C17H19NO4/c1-18-7-6-16-13-9-2-3-10(19)14(13)22-15(16)11(20)4-5-17(16,21)12(18)8-9/h2-3,12,15,19,21H,4-8H2,1H3/t12-,15+,16+,17-/m1/s1","copyable":true},{"label":"InChIKey","value":"UQCNKQCJZOAFTQ-ISWURRPUSA-N","copyable":true},{"label":"CAS number","value":"76-41-5","copyable":true},{"label":"UNII","value":"9VXA968E0C","copyable":true},{"label":"PubChem CID","value":"5284604","copyable":true}],"pharmacokinetics":[{"label":"Elimination half-life","value":"10–12 hours<a href=\"#cite_note-3\"><sup>[3]</sup></a>","copyable":false},{"label":"Duration of action","value":"By mouth: 6–8 hours, Parenteral: 4–6 hours","copyable":false},{"label":"Metabolism","value":"Liver (CYP3A4, glucuronidation)","copyable":false},{"label":"Excretion","value":"Urine, feces","copyable":false},{"label":"Routes of administration","value":"By mouth, buccal, sublingual, intranasal, intravenous, epidural, subcutaneous, intramuscular","copyable":false},{"label":"Dependence liability","value":"High","copyable":false},{"label":"Addiction liability","value":"High","copyable":false}],"toxicity":[],"dosing":null,"salts":[{"title":"Oxymorphone hydrochloride","name":"hydrochloride","slug":"oxymorphone_hydrochloride","drawn":true},{"title":"Oxymorphone hydrobromide","name":"hydrobromide","slug":"oxymorphone_hydrobromide","drawn":true},{"title":"Oxymorphone hydriodide","name":"hydriodide","slug":"oxymorphone_hydriodide","drawn":true}],"esters":[],"chirality":"absolute","stereo_type":null,"optical_activity":null,"stereoisomers":[],"lipinski":{"passes":true,"violations":0},"reagents":[{"reagent":"Marquis","reacts":true,"colors":["#ffffff","#50268d","#50268d"],"description":"magenta > violet"},{"reagent":"Mecke","reacts":true,"colors":["#ffffff","#f0d41d","#51240b"],"description":"yellow > brown"},{"reagent":"Mandelin","reacts":true,"colors":["#f0d41d","#111111"],"description":"black"},{"reagent":"Froehde","reacts":true,"colors":["#ffffff","#0067ce","#50268d"],"description":"blue > violet"}],"atc":[{"code":"N","description":"Nervous system"},{"code":"N02","description":"Analgesics"},{"code":"N02A","description":"Opioids"},{"code":"N02AA","description":"Natural opium alkaloids"},{"code":"N02AA11","description":"Oxymorphone"}],"mesh":[{"name":"Analgesics, Opioid","id":"M0001068"},{"name":"Adjuvants, Anesthesia","id":"M0001144"},{"name":"Narcotics","id":"M0014481"}],"actives":[],"prodrugs":[],"codrug":false,"interactions":[{"target":"OPRM1","mechanisms":["shared target"],"partners":20,"contraindicated":2}],"mechanism":"Oxymorphone interacts predominantly with the opioid mu-receptor. These mu-binding sites are discretely distributed in the human brain, with high densities in the posterior amygdala, hypothalamus, thalamus, nucleus caudatus, putamen, and certain cortical areas. They are also found on the terminal axons of primary afferents within laminae I and II (substantia gelatinosa) of the spinal cord and in the spinal nucleus of the trigeminal nerve. Also, it has been shown that oxymorphone binds to and inhibits GABA inhibitory interneurons via mu-receptors. These interneurons normally inhibit the descending pain inhibition pathway. So, without the inhibitory signals, pain modulation can proceed downstream.","side_effects":{"drug_id":4639,"drug_name":"oxymorphone","url":"https://sideeffects.embl.de/drugs/4639/pt","atc_codes":[],"side_effects":[{"name":"Nausea","cui":"C0027497"},{"name":"Vertigo","cui":"C0042571"},{"name":"Body temperature increased","cui":"C0015967"},{"name":"Constipation","cui":"C0009806"},{"name":"Somnolence","cui":"C2830004"},{"name":"Headache","cui":"C0018681"},{"name":"Vomiting","cui":"C0042963"},{"name":"Hyperhidrosis","cui":"C0020458"},{"name":"Pruritus","cui":"C0033774"},{"name":"Dizziness","cui":"C0012833"},{"name":"Syncope","cui":"C0039070"},{"name":"Dry mouth","cui":"C0043352"},{"name":"Diarrhoea","cui":"C0011991"},{"name":"Asthenia","cui":"C0004093"},{"name":"Fatigue","cui":"C0015672"},{"name":"Insomnia","cui":"C0917801"},{"name":"Abdominal pain","cui":"C0000737"},{"name":"Gastrointestinal pain","cui":"C0687713"},{"name":"Confusional state","cui":"C0009676"},{"name":"Feeling abnormal","cui":"C1443060"},{"name":"Decreased appetite","cui":"C0232462"},{"name":"Anorexia","cui":"C0003123"},{"name":"Amnesia","cui":"C0002622"},{"name":"Nervous system disorder","cui":"C0027765"},{"name":"Convulsion","cui":"C0036572"},{"name":"Memory impairment","cui":"C0233794"},{"name":"Abdominal distension","cui":"C0000731"},{"name":"Anxiety","cui":"C0003467"},{"name":"Apnoea","cui":"C0003578"},{"name":"Atelectasis","cui":"C0004144"},{"name":"Pneumothorax","cui":"C0032326"},{"name":"Mental disorder","cui":"C0004936"},{"name":"Bronchospasm","cui":"C0006266"},{"name":"Chest pain","cui":"C0008031"},{"name":"Dehydration","cui":"C0011175"},{"name":"Dermatitis","cui":"C0011603"},{"name":"Dermatitis atopic","cui":"C0011615"},{"name":"Diplopia","cui":"C0012569"},{"name":"Drug abuse","cui":"C0013146"},{"name":"Dyspepsia","cui":"C0013395"},{"name":"Dyspnoea","cui":"C0013404"},{"name":"Oedema","cui":"C0013604"},{"name":"Eye disorder","cui":"C0015397"},{"name":"Flatulence","cui":"C0016204"},{"name":"Flushing","cui":"C0016382"},{"name":"Gastrointestinal disorder","cui":"C0017178"},{"name":"Hallucination","cui":"C0018524"},{"name":"Head injury","cui":"C0018674"},{"name":"Cardiac disorder","cui":"C0018799"},{"name":"Hypersensitivity","cui":"C0020517"},{"name":"Hypertension","cui":"C0020538"},{"name":"Hypotension","cui":"C0020649"},{"name":"Hypotensive","cui":"C0857353"},{"name":"Orthostatic hypotension","cui":"C0020651"},{"name":"Immune system disorder","cui":"C0021053"},{"name":"Laryngeal oedema","cui":"C0023052"},{"name":"Laryngospasm","cui":"C0023066"},{"name":"Lethargy","cui":"C0023380"},{"name":"Lung disorder","cui":"C0024115"},{"name":"Mediastinal disorder","cui":"C0025061"},{"name":"Miosis","cui":"C0026205"},{"name":"Nervousness","cui":"C0027769"},{"name":"Feeling jittery","cui":"C0549209"},{"name":"Tension","cui":"C0233494"},{"name":"Oliguria","cui":"C0028961"},{"name":"Palpitations","cui":"C0030252"},{"name":"Ileus paralytic","cui":"C0030446"},{"name":"Pneumonia","cui":"C0032285"},{"name":"Withdrawal syndrome","cui":"C0038587"},{"name":"Shock","cui":"C0036974"},{"name":"Loss of consciousness","cui":"C0041657"},{"name":"Tachycardia","cui":"C0039231"},{"name":"Urethral disorder","cui":"C0041969"},{"name":"Urinary tract disorder","cui":"C0042075"},{"name":"Urticaria","cui":"C0042109"},{"name":"Angiopathy","cui":"C0042373"},{"name":"Weight decreased","cui":"C0043096"},{"name":"Urinary retention","cui":"C0080274"},{"name":"Agitation","cui":"C0085631"},{"name":"Pain","cui":"C0030193"},{"name":"Swelling face","cui":"C0151602"},{"name":"Injection site reaction","cui":"C0151735"},{"name":"Intracranial pressure increased","cui":"C0151740"},{"name":"Biliary colic","cui":"C0151824"},{"name":"Urinary hesitation","cui":"C0152032"},{"name":"Malnutrition","cui":"C0162429"},{"name":"Skin disorder","cui":"C0037274"},{"name":"Respiratory rate decreased","cui":"C0231837"},{"name":"Disorientation","cui":"C0233407"},{"name":"Dysphoria","cui":"C0233477"},{"name":"Respiratory depression","cui":"C0235063"},{"name":"Pulmonary function test decreased","cui":"C0855775"},{"name":"Euphoric mood","cui":"C0235146"},{"name":"Vision blurred","cui":"C0344232"},{"name":"Cold sweat","cui":"C0232431"},{"name":"Sticky skin","cui":"C0392162"},{"name":"Bradycardia","cui":"C0428977"},{"name":"Respiratory distress","cui":"C0476273"},{"name":"Visual impairment","cui":"C3665347"},{"name":"Altered state of consciousness","cui":"C0150450"},{"name":"Depressed level of consciousness","cui":"C0549249"},{"name":"Cancer pain","cui":"C0596240"},{"name":"Menopausal symptoms","cui":"C0236075"},{"name":"Hot flush","cui":"C0600142"},{"name":"Drug interaction","cui":"C0687133"},{"name":"Oxygen saturation decreased","cui":"C0746961"},{"name":"Mental status changes","cui":"C0856054"},{"name":"Ureteral spasm","cui":"C0948226"},{"name":"Ileus","cui":"C1258215"},{"name":"Mental retardation","cui":"C0025362"},{"name":"Mental disability","cui":"C1306341"}],"indications":[{"name":"Acute pain","cui":"C0184567"},{"name":"Anxiety","cui":"C0003467"},{"name":"Dyspnoea","cui":"C0013404"},{"name":"Left ventricular dysfunction","cui":"C0242698"},{"name":"Low back pain","cui":"C0024031"},{"name":"Opioid naive","cui":"C1739422"},{"name":"Pain","cui":"C0030193"},{"name":"Postoperative pain","cui":"C0030201"},{"name":"Pulmonary oedema","cui":"C0034063"}]},"effects":{"groups":[["Physical Effects",["Constipation","Cough suppression","Difficulty urinating","Itchiness","Nausea","Pain relief","Pupil constriction","Respiratory depression","Sedation","Stomach cramp"]],["Cognitive Effects",["Anxiety suppression","Cognitive euphoria","Compulsive redosing","Increased music appreciation","Thought deceleration"]],["Visual Effects",["Double vision"]]]},"usernotes":[],"erowid":[],"reddit":[],"legal":[{"jurisdiction":"Australia","status":"Schedule 8","act":null,"refs":[]},{"jurisdiction":"Brazil","status":"A1","act":null,"refs":[4]},{"jurisdiction":"Canada","status":"Schedule I","act":null,"refs":[]},{"jurisdiction":"United Kingdom","status":"Class A","act":"Misuse of Drugs Act 1971","refs":[]},{"jurisdiction":"United States","status":"Schedule II","act":"Controlled Substances Act","refs":[5]},{"jurisdiction":"Germany","status":"Anlage II","act":"Betäubungsmittelgesetz (BtMG)","refs":[]},{"jurisdiction":"Other","status":"SE: Förteckning II, In general: ℞ (Prescription only)","act":null,"refs":[6]}],"members":[],"part_of":[],"links":[{"source":"Wikipedia","url":"https://en.wikipedia.org/wiki/Oxymorphone"},{"source":"PubChem","url":"https://pubchem.ncbi.nlm.nih.gov/compound/5284604"},{"source":"Wikidata","url":"https://www.wikidata.org/wiki/Q423380"},{"source":"DrugBank","url":"https://go.drugbank.com/drugs/DB01192"},{"source":"ChEMBL","url":"https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL963"},{"source":"ChEBI","url":"https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI%3A7865"},{"source":"Common Chemistry","url":"https://commonchemistry.cas.org/detail?cas_rn=76-41-5"},{"source":"HMDB","url":"https://hmdb.ca/metabolites/HMDB0015323"},{"source":"KEGG","url":"https://www.kegg.jp/entry/C08019"},{"source":"EPA DSSTox","url":"https://comptox.epa.gov/dashboard/chemical/details/DTXSID5023409"},{"source":"Effect Index","url":"https://www.effectindex.com/search?q=Oxymorphone"},{"source":"UNII","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/9VXA968E0C"},{"source":"SIDER","url":"https://sideeffects.embl.de/drugs/4639/pt"}],"references":["National Center for Biotechnology Information. PubChem Compound Summary for CID 5284604, Oxymorphone. Accessed November 20, 2026. <a href=https://pubchem.ncbi.nlm.nih.gov/compound/5284604>https://pubchem.ncbi.nlm.nih.gov/compound/5284604</a>","U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Oxymorphone. UNII: 9VXA968E0C. Global Substance Registration System. Accessed November 20, 2026. <a href=https://gsrs.ncats.nih.gov/ginas/app/beta/substances/9VXA968E0C>https://gsrs.ncats.nih.gov/ginas/app/beta/substances/9VXA968E0C</a>","Polsten GR, Wallace MS. Kelley and Firestein&#39;s Textbook of Rheumatology. Elsevier Health Sciences. 21 June 2016.","Anvisa. RDC Nº 784 – Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. 31 March 2023. <a href='https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992'>https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992</a>","Drugs@FDA: FDA Approved Drug Products. www.accessdata.fda.gov. <a href='https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm'>https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm</a>","Läkemedelsverkets föreskrifter (LVFS 2011:10) om förteckningar över narkotika. Läkemedelsverket. <a href='https://www.lakemedelsverket.se/globalassets/dokument/lagar-och-regler/lvfs/lvfs-2011-10-konsoliderad.pdf'>https://www.lakemedelsverket.se/globalassets/dokument/lagar-och-regler/lvfs/lvfs-2011-10-konsoliderad.pdf</a>"],"sources":[{"source":"dosing","status":"missing","fetched_at":"2026-11-20 11:13:11","note":"no dosing statistics"},{"source":"drugspro","status":"ok","fetched_at":"2026-11-20 11:13:07","note":null},{"source":"erowid","status":"missing","fetched_at":"2026-11-20 11:13:07","note":"no Erowid substance of that name"},{"source":"gsrs","status":"ok","fetched_at":"2026-11-20 11:13:09","note":null},{"source":"hmdb","status":"missing","fetched_at":"2026-11-20 11:13:07","note":"hmdb.ca refused automated access to HMDB0015323"},{"source":"kegg","status":"ok","fetched_at":"2026-11-20 11:13:09","note":null},{"source":"pubchem","status":"ok","fetched_at":"2026-11-20 11:13:06","note":null},{"source":"reddit","status":"missing","fetched_at":"2026-11-20 11:13:07","note":"no r/tripreports posts mention it"},{"source":"sider","status":"ok","fetched_at":"2026-11-20 11:13:07","note":null},{"source":"structure","status":"ok","fetched_at":"2026-11-20 11:13:07","note":null},{"source":"wikipedia","status":"ok","fetched_at":"2026-11-20 11:13:07","note":null}],"description":"Oxymorphone is a opioid substance."}